These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

99 related articles for article (PubMed ID: 120353)

  • 21. Interaction between carbenicillin and beta-lactamases from Gram-negative bacteria.
    Bobrowski M; Borowski E
    J Gen Microbiol; 1971 Nov; 68(3):263-72. PubMed ID: 5002807
    [No Abstract]   [Full Text] [Related]  

  • 22. In vitro activity of azlocillin, carbenicillin, mezlocillin and piperacillin against Pseudomonas aeruginosa.
    Høiby N; Bremmelgaard A; Schouenborg P
    Scand J Infect Dis Suppl; 1981; 29():27-30. PubMed ID: 6458882
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Bacteriological investigations with beta-lactamase inhibitors.
    Ullmann U
    Zentralbl Bakteriol Mikrobiol Hyg A Med Mikrobiol Infekt Parasitol; 1982 Jun; 252(2):222-9. PubMed ID: 6289565
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Sensitivity to carbenicillin and ticarcillin, and the beta-lactamases of Pseudomonas aeruginosa in the UK in 1978-79.
    King JD; Farmer T; Reading C; Sutherland R
    J Clin Pathol; 1980 Mar; 33(3):297-301. PubMed ID: 6769973
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [In vitro action of new beta-lactams on hospital strains of Pseudomonas aeruginosa producing beta-lactamases ].
    Moillo-Batt A; Shacoori ZT
    Pathol Biol (Paris); 1982 Jun; 30(6 Pt 2):510-2. PubMed ID: 6812004
    [TBL] [Abstract][Full Text] [Related]  

  • 26. R factors, beta-lactamase, and carbenicillin-resistant Pseudomonas aeruginosa.
    Sykes RB; Richmond MH
    Lancet; 1971 Aug; 2(7720):342-4. PubMed ID: 4105047
    [No Abstract]   [Full Text] [Related]  

  • 27. Bacteriological, pharmacological, and clinical studies of carbenicillin.
    Meyers BR; Sabbaj J; Weinstein L
    Arch Intern Med; 1970 Feb; 125(2):282-6. PubMed ID: 4983746
    [No Abstract]   [Full Text] [Related]  

  • 28. ["Pseudomonas aeruginosa" beta-lactamases and sensitivity to carbenicillin (author's transl)].
    Labia R; Kazmierczak A; Philippon A; Le Goffic F; Faye JC; Goldstein FW; Acar JF
    Ann Microbiol (Paris); 1975; 126A(4):449-59. PubMed ID: 812406
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Mechanisms of azlocillin resistance in Pseudomonas aeruginosa].
    Labia R; Morand A; Ben Yaghlane H
    Presse Med; 1984 Mar; 13(13):777-9. PubMed ID: 6231594
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Resistance of penicillins and cephalosporins to beta-lactamases from Gram-negative bacilli: some correlations with antibacterial activity.
    Sabath LD; Finland M
    Ann N Y Acad Sci; 1967 Sep; 145(2):237-47. PubMed ID: 4998177
    [No Abstract]   [Full Text] [Related]  

  • 31. Penicillin-resistant mechanisms in Pseudomonas aeruginosa: effects of penicillin G and carbenicillin on transpeptidase and C -alanine carboxypeptidase activities.
    Suginaka H; Ichikawa A; Kotani S
    Antimicrob Agents Chemother; 1974 Dec; 6(6):672-5. PubMed ID: 4217580
    [TBL] [Abstract][Full Text] [Related]  

  • 32. R-factor mediated resistance to penicillins which does not involve a beta-lactamase.
    Curtis NA; Richmond MH; Stanisich V
    J Gen Microbiol; 1973 Nov; 79(1):163-6. PubMed ID: 4204236
    [No Abstract]   [Full Text] [Related]  

  • 33. Disodium D-6-[alpha-(1,2,4-triazine-3,5-dione-6-carboxamido)-4-hydroxyphenylacetamido]penicillanate, BL-P1908.
    Baker SR; Holdrege CT; McGregor DN
    J Antibiot (Tokyo); 1979 May; 32(5):468-71. PubMed ID: 118961
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Mechanisms of beta-lactam resistance in British isolates of Pseudomonas aeruginosa.
    Williams RJ; Livermore DM; Lindridge MA; Said AA; Williams JD
    J Med Microbiol; 1984 Jun; 17(3):283-93. PubMed ID: 6327987
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Comparison of in vitro bacteriostatic effect of five betalactamins against Pseudomonas aeruginosa (author's transl)].
    Lesage D; Delisle-Mizon F; Denis C; Vergez P; Daguet GL
    Pathol Biol (Paris); 1982 Jun; 30(6):440-3. PubMed ID: 6213917
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [In vitro examination of some new penicillin derivatives with activity against Pseudomonas aeruginosa: azlocillin, mezlocillin and piperacillin compared with carbenicillin].
    Høiby N; Bremmelgaard A; Schouenborg P
    Ugeskr Laeger; 1979 Oct; 141(41):2815-8. PubMed ID: 120049
    [No Abstract]   [Full Text] [Related]  

  • 37. [Relationship between the structure and function of polysynthetic penicillins].
    Naĭler Dzh
    Antibiotiki; 1971 Oct; 16(10):877-82. PubMed ID: 5003055
    [No Abstract]   [Full Text] [Related]  

  • 38. Azlocillin: a new broad spectrum penicillin.
    Sanders CC
    J Antimicrob Chemother; 1983 May; 11 Suppl B():21-31. PubMed ID: 6619029
    [TBL] [Abstract][Full Text] [Related]  

  • 39. In vitro activity of piperacillin/tazobactam against 615 Pseudomonas aeruginosa strains isolated in intensive care units.
    Bonfiglio G; Laksai Y; Franceschini N; Perilli M; Segatore B; Bianchi C; Stefani S; Amicosante G; Nicoletti G
    Chemotherapy; 1998; 44(5):305-12. PubMed ID: 9732144
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Combined action of beta-lactum antibiotics against gram-negative bacilli.
    Bobrowski MM; Gebicka K; Borowski J
    J Hyg Epidemiol Microbiol Immunol; 1973; 17(2):129-40. PubMed ID: 4199760
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.